Michael May, PhD - Bristol Myers Squibb

Michael May, PhD currently serves as the countrywide medical director for Bristol Myers Squibb in Germany. Since joining the company more than 13 years ago, Michael has worked in a variety of roles across disease areas, overseeing medical operations in oncology, immunoscience and virology.  

In his current role, Michael leads the German medical organization, overseeing local medical strategy and execution. His main focus is to drive local clinical research to expedite access to innovative therapies for patients, by collaborating with leading scientific institutions and academic networks. 

In addition to his contributions locally within the German organization, Michael also works to foster close relationships with other Bristol Myers Squibb sites, including those across Europe and the U.S., finding continuity in work to speed scientific discovery. 

“We work closely to foster synergies between sites in order to create new ideas that can help us work better together to innovate for patients with high unmet need,” says May. 

Michael also serves as a board member of the Bristol Myers Squibb Immuno-Oncology Foundation in Germany. 

Michael has extensive experience in cancer research. Prior to joining Bristol Myers Squibb, he spent time at other life sciences companies in Germany such as Pharmacia and Pfizer. He completed his undergraduate degree in biology from the University of Erlangen and went on to earn his PhD from its Institute for Clinical and Molecular Virology before completing his post-doctoral work at the Institute of Genetics and Molecular and Cellular Biology in Strasbourg, France.